|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Oct 23, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Marketable securities, available for sale | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets in discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Investment in unconsolidated affiliates | ||||||||||||||||||||
| Prepaid expenses, net of current portion | ||||||||||||||||||||
| Operating lease right-of-use asset, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Non-current assets in discontinued operations | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Affiliated Entity | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued diagnostic services | ||||||||||||||||||||
| Accrued advertising and other allowances | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Short-term loan payable, net of discount | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total short-term loan payable, net of discount | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Short-term convertible notes payable, net of discount of $451 and $157, respectively | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities in discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Long-term debt, net of discount of $341 | ||||||||||||||||||||
| Secured long-term debt, net of discount of $324 and $341 | ||||||||||||||||||||
| Unsecured debt | ||||||||||||||||||||
| 2023 Note | ||||||||||||||||||||
| September 2020 Notes | ||||||||||||||||||||
| JXVII Note | ||||||||||||||||||||
| ERC Claim | ||||||||||||||||||||
| Total unsecured debt | ||||||||||||||||||||
| Due to sellers (see Note 3) | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Finance lease liabilities, net of current portion | ||||||||||||||||||||
| Non-current liabilities in discontinued operations | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||||
| Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding | ||||||||||||||||||||
| Common stock authorized 1,000,000,000, $0.0005 par value, 14,016,024 and 8,966,406 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost, 869,208 and 869,208 shares, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFECIT) | ||||||||||||||||||||
Loading...